In Chicago Here I Come- ASCO 2016, I wrote about the sessions I had hoped to attend. But it turns out even after planning a schedule in advance I still had to make adjustments. I didn't attend the Patient and Survivor Care, the Cancer Prevention and Epidemiology or the Genomics and Biomarker sessions. But I did add the Developmental Therapeutics and Transitional Research session on Biosimilars and the ASCO Book Club session When Breathe Becomes Air as wells as a special advocate session on TAPUR to my schedule.
Some more schedule adjustments were made when I learned I would have the privilege of hearing Vice President Biden address the meeting attendees. It was a great experience and an ASCO experience I will not forget. Hearing him talk about the Cancer Moonshot program and how important collaboration and big data is to program gave me hope that it will a success.
- Ovarian Cancer Research: IV vs IP chemotherapy, neoadjuvant chemotherapy and immunotherapy/targeted therapy study results
- Endometrial and Cervical Cancer studies
- Liquid Biopsies in Precision Medicine
- Biosimilars in Cancer Treatment
- ASCO's TAPUR Study
I look forward to sharing what I learned with my readers.
Every Day is a Blessing